ACBD (lek)
С Википедије, слободне енциклопедије
| |
| Nazivi | |
|---|---|
| IUPAC naziv
1-Aminociklobutan-1,3-dikarboksilna kiselina
| |
Drugi nazivi
| |
| Identifikacija | |
3D model (Jmol)
|
|
| EC broj | 631-436-5 |
| |
| Svojstva | |
| C6H9NO4 | |
| Molarna masa | 159,14 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
ACBD ili 1-Aminociklobutan-1,3-dikarboksilna kiselina je agonist NMDA receptora.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.
| AMPAR |
|
|---|---|
| KAR |
|
| NMDAR |
|
